Sudeep Pharma

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE0QPI01025
NSEID: SUDEEPPHRM
BSEID: 544619

INR

662.15

-8.1 (-1.21%)

BSENSE

Dec 05

BSE+NSE Vol: 11.93 lacs

Click here to access the older version

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

11.93 lacs (-78.24%) Volume

Shareholding (Nov 2025)

FII

1.54%

Held by 65 FIIs

DII

10.92%

Held by 16 DIIs

Promoter

76.15%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 7,546 Cr (Mid Cap)

P/E

78.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.17

Return on Equity

22.26%

Price to Book

17.60

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Closure of Trading Window

28-Nov-2025 | Source : BSE

Intimation for Closure of Trading window w.e.f. 28th November 2025 till publication of Un-audited Financial Results for the quarter and half year ended 30th September 2025

Listing of Equity Shares of Sudeep Pharma Ltd

28-Nov-2025 | Source : BSE

Trading Members of the Exchange are hereby informed that effective from November 28 2025 the Equity Shares of Sudeep Pharma Ltd (Scrip Code: 544619) are listed and admitted to dealings on the Exchange in the list of B Group Securities. For further details please refer to the notice no. 20251127- 58 dated November 27 2025.

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

Debt to EBITDA (avg)

0.77

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

16.30%

ROCE (avg)

29.12%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

17.39

EV to EBIT

59.60

EV to EBITDA

56.85

EV to Capital Employed

15.01

EV to Sales

21.17

PEG Ratio

Dividend Yield

ROCE (Latest)

25.18%

ROE (Latest)

22.26%

Technicals key factors

Indicator

Weekly

Monthly

No records

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Nov 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 15 Schemes (3.44%)

FIIs

Held by 65 FIIs (1.54%)

Promoter with highest holding

Riva Resources Private Limited (40.35%)

Highest Public shareholder

Nuvama Crossover Opportunities Fund - Series Iii (3.42%)

Individual Investors Holdings

7.52%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Sudeep Pharma"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Sudeep Pharma"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Sudeep Pharma"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Sudeep Pharma"
  }
]

Company CV

About Sudeep Pharma Ltd

Sudeep Pharma Ltd

Mid Cap

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available